216 related articles for article (PubMed ID: 11412101)
41. Residues of the fourth transmembrane segments of the Na,K-ATPase and the gastric H,K-ATPase contribute to cation selectivity.
Mense M; Dunbar LA; Blostein R; Caplan MJ
J Biol Chem; 2000 Jan; 275(3):1749-56. PubMed ID: 10636871
[TBL] [Abstract][Full Text] [Related]
42. Analysis of the membrane domain of the gastric H(+)/K(+)-ATPase.
Munson K; Lambrecht N; Shin JM; Sachs G
J Exp Biol; 2000 Jan; 203(Pt 1):161-70. PubMed ID: 10600685
[TBL] [Abstract][Full Text] [Related]
43. [Structure-function study on gastric proton pump].
Asano S
Yakugaku Zasshi; 1997 Jul; 117(7):379-93. PubMed ID: 9261211
[TBL] [Abstract][Full Text] [Related]
44. Deceleration of the E1P-E2P transition and ion transport by mutation of potentially salt bridge-forming residues Lys-791 and Glu-820 in gastric H+/K+-ATPase.
Dürr KL; Seuffert I; Friedrich T
J Biol Chem; 2010 Dec; 285(50):39366-79. PubMed ID: 20921224
[TBL] [Abstract][Full Text] [Related]
45. Role of homologous ASP334 and GLU319 in human non-gastric H,K- and Na,K-ATPases in cardiac glycoside binding.
Radkov R; Kharoubi-Hess S; Schaer D; Modyanov NN; Geering K; Horisberger JD
Biochem Biophys Res Commun; 2007 Apr; 356(1):142-6. PubMed ID: 17349614
[TBL] [Abstract][Full Text] [Related]
46. Molecular identification of Sch28080-sensitive K-ATPase activities in the mouse kidney.
Dherbecourt O; Cheval L; Bloch-Faure M; Meneton P; Doucet A
Pflugers Arch; 2006 Mar; 451(6):769-75. PubMed ID: 16208521
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological profiles of the murine gastric and colonic H,K-ATPases.
Shao J; Gumz ML; Cain BD; Xia SL; Shull GE; van Driel IR; Wingo CS
Biochim Biophys Acta; 2010 Sep; 1800(9):906-11. PubMed ID: 20594946
[TBL] [Abstract][Full Text] [Related]
48. The carbonyl group of glutamic acid-795 is essential for gastric H+,K+-ATPase activity.
Hermsen HP; Koenderink JB; Swarts HG; De Pont JJ
Biochemistry; 2000 Feb; 39(6):1330-7. PubMed ID: 10684613
[TBL] [Abstract][Full Text] [Related]
49. Cation stoichiometry and cation pathway in the Na,K-ATPase and nongastric H,K-ATPase.
Horisberger JD; Guennoun S; Burnay M; Geering K
Ann N Y Acad Sci; 2003 Apr; 986():127-32. PubMed ID: 12763785
[TBL] [Abstract][Full Text] [Related]
50. A conformation-specific interhelical salt bridge in the K+ binding site of gastric H,K-ATPase.
Koenderink JB; Swarts HG; Willems PH; Krieger E; De Pont JJ
J Biol Chem; 2004 Apr; 279(16):16417-24. PubMed ID: 14761952
[TBL] [Abstract][Full Text] [Related]
51. Melittin inhibition of the gastric (H+ + K+) ATPase and photoaffinity labeling with [125I]azidosalicylyl melittin.
Cuppoletti J; Blumenthal KM; Malinowska DH
Arch Biochem Biophys; 1989 Nov; 275(1):263-70. PubMed ID: 2554808
[TBL] [Abstract][Full Text] [Related]
52. The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump.
Asano S; Yoshida A; Yashiro H; Kobayashi Y; Morisato A; Ogawa H; Takeguchi N; Morii M
J Biol Chem; 2004 Apr; 279(14):13968-75. PubMed ID: 14699149
[TBL] [Abstract][Full Text] [Related]
53. The cryo-EM structure of gastric H
Abe K; Shimokawa J; Naito M; Munson K; Vagin O; Sachs G; Suzuki H; Tani K; Fujiyoshi Y
Sci Rep; 2017 Jul; 7(1):6632. PubMed ID: 28747707
[TBL] [Abstract][Full Text] [Related]
54. The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.
Scott DR; Munson KB; Marcus EA; Lambrecht NW; Sachs G
Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1315-26. PubMed ID: 26423447
[TBL] [Abstract][Full Text] [Related]
55. Catalytic function of nongastric H,K-ATPase expressed in Sf-21 insect cells.
Adams G; Tillekeratne M; Yu C; Pestov NB; Modyanov NN
Biochemistry; 2001 May; 40(19):5765-76. PubMed ID: 11341842
[TBL] [Abstract][Full Text] [Related]
56. Functional association between K+-Cl- cotransporter-4 and H+,K+-ATPase in the apical canalicular membrane of gastric parietal cells.
Fujii T; Takahashi Y; Ikari A; Morii M; Tabuchi Y; Tsukada K; Takeguchi N; Sakai H
J Biol Chem; 2009 Jan; 284(1):619-629. PubMed ID: 18984587
[TBL] [Abstract][Full Text] [Related]
57. Significance of lysine/glycine cluster structure in gastric H+,K+-ATPase.
Asano S; Miwa K; Yashiro H; Tabuchi Y; Takeguchi N
Jpn J Physiol; 2000 Aug; 50(4):419-28. PubMed ID: 11082540
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
[TBL] [Abstract][Full Text] [Related]
59. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
Hori Y; Imanishi A; Matsukawa J; Tsukimi Y; Nishida H; Arikawa Y; Hirase K; Kajino M; Inatomi N
J Pharmacol Exp Ther; 2010 Oct; 335(1):231-8. PubMed ID: 20624992
[TBL] [Abstract][Full Text] [Related]
60. The human non-gastric H,K-ATPase has a different cation specificity than the rat enzyme.
Swarts HG; Koenderink JB; Willems PH; De Pont JJ
Biochim Biophys Acta; 2007 Mar; 1768(3):580-9. PubMed ID: 17137554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
